This site is intended for healthcare professionals

SGLT2 inhibitors in type 2 diabetes: Recommendations within updated NICE guideline NG28

Posted 14 Feb 2022

Dr Anish Kotecha MRCGP FAcadMEd MBBCh BSc

Dr Anish Kotecha explores the recommendations on sodium–glucose cotransporter 2 (SGLT2) inhibitors within updated guidance on type 2 diabetes management in adults from NICE.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page